9^th International Conference on Tropical Medicine and Infectious Diseases November 25-26, 2020 Singapore City, Singapore

PhD from Cairo University, postdoctoral studies at Strathclyde Universitym UK and received a FRCU GRANT 840501 on Drug Pharmacokinetics in Schistosomiasis. She is a Board Member of the Egyptian Society of Pharmacology and Experimental Therapeutics, Editor in Chief of the EJBCP, Member of the Ethics Committee at Theodor Bilharz Institute, Head of the Scientific Promotion Committee at the National Organization for Drug Control and Research, Supervised more than 70 M.Sc. and Ph.D. students , Attended and made presentations at more than 90 Conference, National and International, around 90 publications in International and National Journals,

Pharmocology, Drug Interactions

Dr. Azizollah, Arbabisarjou, RN,MScN, PhD, obtained his first academic degree in 1997 in the Nursing management field. He joined as faculty member to Zahedan University of Medical Sciences, IRAN. He received his doctorate from University of Isfahan in field of Educational Administration in 2011.He has been the manager of Curriculum development in EDC. He has published numerous referred papers about patient teaching, knowledge management, Quality in education, , Internal evaluation, On- line evaluation, Higher Education services, Principal’s Management Styles on Teacher’s Job Satisfaction, ICT and QoL, Management style , Justice and Organizational Citizenship behavior and organizational Identity Emotional Intelligence, Spiritual Intelligence and so on in ISI, PubMed and Scopus indexed journal. Dr. Arbabisarjou is teaching for Master students of Information Technology management, MBA and Educational Administration. Also, he has conducted numerous consulting and research works for masters’ student and colleagues.

Nursing Care, Health Care, Primary Health

Simon Daefler is a Professor of medicine at department of infectious diseases, Mount Sinai School of Medicine laboratory of systems biology in infectious diseases, New York, USA.

Dr. Simon Daefler research interests are focused on two intracellular pathogens, salmonella and francisella. His work with these pathogens dissects out intracellular host pathogen interactions that allow survival of the organism within key target cells including the macrophage and heptocate. These pathogens are important subjects of study both because of their impact on world health and their potential use as a tool for bioterrorism. Dr. Daefler is Executive Director of the Biosafety Laboratory Level 3+ (BSL3+) at Mount Sinai School of Medicine. He also has extensive experience as an educator and mentor.

Dr. Qiang "Shawn" Chen obtained his PhD in biochemistry from University of Arizona and postdoctoral training in molecular genetics from University of Minnesota. He is currently an Associate Professor in the Center for Infectious Diseases and Vaccinology, the Biodesign Institute and the School of Life Sciences at Arizona State University. Dr. Chen spent more than ten years in the biotechnology and pharmaceutical industry directing research in therapeutic protein development in both plant and mammalian cell culture systems. Prior to joining ASU, Dr. Chen was the Associate Director of division of protein chemistry at Cardinal Health and a Sr. Scientist at Monsanto.

Dr. Chen’s research interests include the development of protein-based therapeutics and vaccines in plant systems. His laboratory is currently focusing on optimizing the expression and assembly of monoclonal antibodies and designing novel mAb fusion proteins to enhance their targeting, safety, and efficacy against infectious diseases and cancers.

Polly Matzinger has worked as a bartender, carpenter, jazz musician, playboy bunny, and dog trainer. She is currently chief of the ghost lab and the section on T-Cell Tolerance and Memory. She worried for years that the dominant model of immunity does not explain a wealth of accumulated data and suggested an alternative, the Danger model, which suggests that the immune system is far less concerned with things that are foreign than with those that do damage. This model, whose two major tenets z most of what the immune system seems to do right, as well as most of what it appears to do wrong, covering areas as transplantation,autoimmunity, and the immunobiology of tumors. The model has been the subject of a BBC "horizon" film and was featured in three other films about immunity, as well as countless articles in both the scientific and the lay press. In 2013, her section was assigned to the Laboratory of Immunogenetics.

Danger model of immunity,Tissue-based class control,Immune tolerance and activation

Anil Ojha is from Department of Infectious Diseases and Microbiology,Graduate School of Public Health, University of Pittsburgh, USA.

Anil Ojha research interests is focused on understanding how the spontaneous nature of M. tuberculosis to grow as an organized community influences its ability to endure antibiotics and other stresses.